ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
公司代碼ASPI
公司名稱ASP Isotopes Inc
上市日期Nov 10, 2022
CEOAinscow (Robert)
員工數量136
證券類型Ordinary Share
年結日Nov 10
公司地址601 Pennsylvania Avenue Nw
城市WASHINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編20004
電話12027562245
網址https://aspisotopes.com/
公司代碼ASPI
上市日期Nov 10, 2022
CEOAinscow (Robert)